 |
DAEJEON, South Korea, Feb. 25, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today the completion of last patient last visit in its Phase Ib combination trial for mTNBC (metastatic Triple-Negative Breast Cancer)...
Ransomware is the single biggest cyberthreat facing businesses today. Being attacked by cybercrooks using ransomware is a matter of when, not if. So, if you’re going to come under attack, what are some preventative measures ...
Leading helicopter and software firms join forces to enhance safety A leading global helicopter operator and an innovative software firm are teaming up to deliver real-time risk management tools that will lift the bar on helic...
The decision to extend pandemic leave payments is a common sense step forward, Business Council chief executive Jennifer Westacott said. “While government mandated isolation rules are in place, it makes sense to keep carefully ta...
